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CASES: MATERIALS AND METHODS
In this study we investigate the demographic,
clinical and laboratory features of six human
cases of human granulocytic anaplasmosis (HGA)
in Crete, Greece.
Six patients, residents of the city of Chania,
Crete, were hospitalised in the General Hospital
of Chania with clinical manifestations and labo-
ratory ﬁndings suggestive of acute A. phagocyto-
philum infection. Blood samples were taken from
all patients on admission before the administra-
tion of antibiotics. Acute-phase serum samples
were tested using an indirect immunoﬂuores-
cence assay (IFA) for the presence of IgG and IgM
antibodies against A. phagocytophilum antigen
(Focus Diagnostics, CA, USA), according to the
manufacturer’s recommendations (cut-off for pos-
itivity IgG‡1 ⁄ 64 and IgM‡1 ⁄ 20). Whole blood
samples were tested by PCR-sequencing analysis
of the 16s rRNA gene. DNA extraction was
carried out using the QIAamp DNA blood mini
kit (Qiagen, Hilden, Germany). PCR reactions
were carried out using the primer set EHR16SD–
EHR16SR targeting a fragment of 345 bp of the
16s rRNA gene of Anaplasmataceae using the
conditions previously described [4]. Positive PCR
products were directly sequenced using the
sequencer CEQ 8000 Beckman Coulter. Three
consecutive blood samples were taken for culture
from each patient. Serological testing for sus-
pected potential pathogens that are endemic in
the area was also performed.
Six patients were diagnosed as having acute
A. phagocytophilum infection. Four infections were
acquired in September 2006, one in August 2007
and one in September 2007. The mean age was
46.7 years old, ranging from 17 to 69 years old.
Five patients were males. Three out of six patients
reported contact with wild animals within
1 month before the onset of symptoms. None of
the patients had travelled recently. Demographic
characteristics, clinical presentation and labora-
tory ﬁndings are presented in Table 1.
Symptoms persisted for 2–6 days before pre-
sentation. On admission, fever was present in all
of the six patients and was accompanied by chills
in two patients. Other symptoms observed were a
maculopapular rash of the trunk (3 ⁄ 6), headache
(2 ⁄ 6), malaise (2 ⁄ 6), splenomegaly (2 ⁄ 6), cervical
lymphadenopathy (1 ⁄ 6), and gastrointestinal dis-
turbances (1 ⁄ 6 patients).
Common laboratory abnormalities found were
high lactate dehydrogenase titres (all patients),
elevated transaminases (5 ⁄ 6), elevated serum
C-reactive protein (4 ⁄ 6), thrombocytopenia (4 ⁄ 6),
and leucopenia (2 ⁄ 6 patients).
All blood cultures were negative for common
pathogens. Acute infection by other suspected
pathogens included in the differential diagnosis
was ruled out.
All patients revealed IgM antibodies with titres
ranging from 1 ⁄ 20 to 1 ⁄ 40. Only one patient
revealed both IgM and IgG antibodies against
Anaplasma phagocytophilum (IgG 1 ⁄ 128, IgM 1 ⁄ 40).
DNA sequences of the PCR products in all
patients (Genbank number EU448142), when
compared using nucleotide Blast (National Center
for Biotechnology Information) (http://
www.ncbi.nlm.nih.gov/BLAST), revealed 100%
identity with each other and 98% identity with
Anaplasma sp deposited sequences (EU448141,
Anaplasma sp. panagCy 16S ribosomal RNA gene;
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EU090185, Anaplasma sp. 5 16S ribosomal RNA
gene; EU090184, Anaplasma sp. 4 16S ribosomal
RNA gene; DQ648489, Anaplasma phagocytophilum
16S ribosomal RNA gene).
Treatment was administered to all patients on
the day of admission. Four patients were treated
with doxycycline and ciproﬂoxacin and two
patients were treated with doxycycline and amox-
icillin ⁄ clavulanate. One patient’s clinical condi-
tion did not improve and ciproﬂoxacin was
replaced by chloramphenicol on day three of
treatment. Defervescence was observed on a
mean of 5 days after treatment onset (range, 3–
7 days).
DISCUSSION
Data concerning the prevalence of HGA in
Europe are limited, but increased medical aware-
ness has led to the detection of human cases in
several countries [2]. The non-speciﬁc clinical
manifestations of the disease make the diagnosis
difﬁcult, but high suspicion should arise when
compatible epidemiological information is avail-
able. In Greece, other tick-borne diseases have
been reported and in previous studies various tick
species have been identiﬁed [5]. However, the
Ixodes ricinus tick [4], regarded as the main vector
in Europe, is not a common tick species in Crete;
moreover, common reservoirs of A. phagocytophi-
lum, such as white-tailed deer, white-footed mice
and dusky-footed wood rats [1], are not present in
Greece. Therefore, the suggestion that different
reservoirs and vectors are involved in the trans-
mission cycle of HGA in the region should be
investigated.
The diagnosis of HGA is based on serologic
evidence and ⁄ or a positive PCR assay [1,2]. In our
study, serological and clinical evidence of acute
A. phagocytophilum infection were further con-
ﬁrmed by PCR and sequence analysis. To our
knowledge, this is the ﬁrst description of human
cases of acute HGA in Greece.
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Table 1. Demographic data, clinical characteristics and laboratory ﬁndings upon presentation in six human granulocytic
anaplasmosis patients in the city of Chania, Crete, Greece
Patient number 1 2 3 4 5 6
Age 53 56 17 69 62 17
Sex M M F M M M
Day of illness 3 2 6 NR 3 2
Contact with wild animals Rodents, goats, sheep Rodents, goats, sheep, pigeons NR NR Rodents NR
Highest temperature 38 39.5 40 38.5 39.6 40
Rigor No No No Yes Yes No
Maculopapular rash No No No Yes Yes Yes
Headache Yes Yes No No No No
Malaise Yes No Yes No No No
Splenomegaly No No Yes No Yes No
Other Cervical lymphadenopathy No Abdominal pain, nausea, constipation No No No
AST (U ⁄L)a 125 124 393 20 139 115
ALT (U ⁄L)a 74 121 208 20 118 104
LDH (U ⁄L)b 745 572 946 264 894 498
CRP (mg ⁄dL)c NR NR 8.6 4.6 9.5 6.3
Platelets count (X 109 ⁄L)d 98 123 145 194 72 192
WBC count (X 109 ⁄L)e 5.1 3.8 7.0 6.9 4.8 5.1
NR, not reported; anormal value, 0–40 U ⁄L; bnormal value, <230 U ⁄L; cnormal value, <0.35 mg ⁄dL; dnormal value, 150–450 · 109 ⁄L; enormal value, 5–10 · 109 ⁄L.
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